Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit

Detalles Bibliográficos
Autores principales: Bonadona, A, Pavese, P, Hamidfar, R, Pernod, G, Stouls, T, Pison, C, Letoublon, C, Barnoud, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333542/
http://dx.doi.org/10.1186/cc1583
_version_ 1782230466304147456
author Bonadona, A
Pavese, P
Hamidfar, R
Pernod, G
Stouls, T
Pison, C
Letoublon, C
Barnoud, D
author_facet Bonadona, A
Pavese, P
Hamidfar, R
Pernod, G
Stouls, T
Pison, C
Letoublon, C
Barnoud, D
author_sort Bonadona, A
collection PubMed
description
format Online
Article
Text
id pubmed-3333542
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33335422012-04-24 Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit Bonadona, A Pavese, P Hamidfar, R Pernod, G Stouls, T Pison, C Letoublon, C Barnoud, D Crit Care Meeting Abstract BioMed Central 2002 2002-03-01 /pmc/articles/PMC3333542/ http://dx.doi.org/10.1186/cc1583 Text en
spellingShingle Meeting Abstract
Bonadona, A
Pavese, P
Hamidfar, R
Pernod, G
Stouls, T
Pison, C
Letoublon, C
Barnoud, D
Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title_full Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title_fullStr Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title_full_unstemmed Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title_short Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
title_sort recombinant activated factor vii (rfviia-novoseven(®)-novonordisk) treatment of bleeding complications in intensive care unit
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333542/
http://dx.doi.org/10.1186/cc1583
work_keys_str_mv AT bonadonaa recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT pavesep recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT hamidfarr recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT pernodg recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT stoulst recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT pisonc recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT letoublonc recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit
AT barnoudd recombinantactivatedfactorviirfviianovosevennovonordisktreatmentofbleedingcomplicationsinintensivecareunit

Ejemplares similares